NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 158 filers reported holding NOVAVAX INC in Q2 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $241,000 | -56.1% | 131,205 | -55.1% | 0.04% | -28.1% |
| Q3 2018 | $549,000 | -18.2% | 292,125 | -41.7% | 0.06% | -90.4% |
| Q2 2018 | $671,000 | -43.4% | 500,964 | -11.3% | 0.59% | -42.4% |
| Q1 2018 | $1,186,000 | +260.5% | 564,544 | +112.9% | 1.03% | +149.2% |
| Q4 2017 | $329,000 | -6.3% | 265,206 | -14.0% | 0.41% | +778.7% |
| Q3 2017 | $351,000 | +9.0% | 308,286 | +10.1% | 0.05% | -2.1% |
| Q2 2017 | $322,000 | +15.8% | 280,087 | +29.1% | 0.05% | -4.0% |
| Q1 2017 | $278,000 | +12.6% | 216,960 | +10.6% | 0.05% | -32.4% |
| Q4 2016 | $247,000 | +216.7% | 196,162 | +422.4% | 0.07% | +94.7% |
| Q3 2016 | $78,000 | -71.4% | 37,550 | 0.0% | 0.04% | -81.3% |
| Q2 2016 | $273,000 | +71.7% | 37,550 | +22.0% | 0.20% | -7.3% |
| Q1 2016 | $159,000 | -42.0% | 30,787 | -5.9% | 0.22% | -70.9% |
| Q4 2015 | $274,000 | – | 32,714 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |